Endocarditis caused by Stenotrophomonas maltophilia

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Clinical Case Study

Background:

• Stenotrophomonas maltophilia is an opportunistic pathogen increasingly implicated in hospital-acquired infections.
• The bacterium is known for its intrinsic and acquired multidrug resistance, posing treatment challenges.
• While S. maltophilia causes various infections, endocarditis is an exceptionally rare manifestation.

Observation:

• A case of endocarditis in a 40-year-old male patient with a history of aortic valve replacement is presented.
• Blood cultures identified Stenotrophomonas maltophilia as the causative agent.
• The isolated S. maltophilia strain exhibited multidrug resistance to a range of common antibiotics.

Findings:

• Successful treatment of S. maltophilia endocarditis was achieved using a combination of ticarcillin-clavulanate and trimethoprim-sulfamethoxazole.
• The chosen antibiotics were effective against the multidrug-resistant strain, leading to patient recovery.
• This case highlights the potential for S. maltophilia to cause severe infections like endocarditis, even in prosthetic valves.

Implications:

• This case underscores the importance of considering Stenotrophomonas maltophilia in the differential diagnosis of endocarditis, particularly in patients with prosthetic valves or recent hospitalizations.
• The successful use of ticarcillin-clavulanate and trimethoprim-sulfamethoxazole provides valuable therapeutic insights for managing rare S. maltophilia infections.
• Further research into the pathogenicity and optimal treatment strategies for S. maltophilia endocarditis is warranted to address its growing clinical significance.